Sign inJoin waitlistJoin the waitlist

James Geller

., Associate Physician of Pediatrics, UC San Diego · University of California (San Diego) Medical Center

Credentials: · · ·

History

University of California (San Diego) Medical Center
Present

St Jude Children's Research Hospital
2000–2001
New York Medical College
1997–2000
Faculty of Medicine
1993–1997

Research

Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration
Review · Journal of Clinical Oncology · 2015 · 290 citations
Wilms tumour
Review · Nature Reviews Disease Primers · 2021 · 187 citations
A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors
Clinical Cancer Research · 2017 · 152 citations

Elizabeth Mullen
64 papers
Jeffrey Dome
63 papers
PE
Peter Erhlich
47 papers
EP
Elizabeth Perlman
40 papers
Geetika Khanna
38 papers
GT
Greg Tiao
33 papers
John Kalapurakal
25 papers
Nicholas Cost
24 papers · 9 as a fellow
EG
Eric Gratias
23 papers
Alexander Bondoc
19 papers
Arnold Paulino
16 papers
Kenneth Gow
16 papers

Grants

Phase I Study of HSV1716 in Pediatric Non-CNS Solid Tumors,IND 13196 12/04/2006
Food and Drug Administration · R01
Contact PI · $191.2K · Research Inst Nationwide Children's Hosp
2010–2013

Clinical trials

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Principal investigator · Recruiting · Phase 2
Children's Oncology Group
2020–2027
A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC)
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
2019–2026
Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma
Principal investigator · Completed · Phase 2
Children's Oncology Group
2015–2021
VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors
Principal investigator · Completed · Phase 1
Children's Oncology Group
2014–2017